BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 19207859)

  • 1. The cost-effectiveness of increasing kidney transplantation and home-based dialysis.
    Howard K; Salkeld G; White S; McDonald S; Chadban S; Craig JC; Cass A
    Nephrology (Carlton); 2009 Feb; 14(1):123-32. PubMed ID: 19207859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis.
    Agar JW; Knight RJ; Simmonds RE; Boddington JM; Waldron CM; Somerville CA
    Nephrology (Carlton); 2005 Dec; 10(6):557-70. PubMed ID: 16354238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of renal replacement therapy in Austria.
    Haller M; Gutjahr G; Kramar R; Harnoncourt F; Oberbauer R
    Nephrol Dial Transplant; 2011 Sep; 26(9):2988-95. PubMed ID: 21310740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy.
    Kontodimopoulos N; Niakas D
    Health Policy; 2008 Apr; 86(1):85-96. PubMed ID: 17996975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home haemodialysis-international trends and variation.
    MacGregor MS; Agar JW; Blagg CR
    Nephrol Dial Transplant; 2006 Jul; 21(7):1934-45. PubMed ID: 16537659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in patients on home haemodialysis in England and Wales, 1997-2005: a comparative cohort analysis.
    Nitsch D; Steenkamp R; Tomson CR; Roderick P; Ansell D; MacGregor MS
    Nephrol Dial Transplant; 2011 May; 26(5):1670-7. PubMed ID: 20841489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis and health-related quality of life of home and self-care satellite haemodialysis.
    Malmström RK; Roine RP; Heikkilä A; Räsänen P; Sintonen H; Muroma-Karttunen R; Honkanen E
    Nephrol Dial Transplant; 2008 Jun; 23(6):1990-6. PubMed ID: 18223263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population.
    Liem YS; Wong JB; Winkelmayer WC; Weimar W; Wetzels JF; de Charro FT; Kaandorp GC; Stijnen T; Hunink MG
    Nephrol Dial Transplant; 2012 Jan; 27(1):429-34. PubMed ID: 21606383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricting cadaveric kidney transplantation based on age: the impact on efficiency and equity.
    Quinn RR; Manns BJ; McLaughlin KM
    Transplant Proc; 2007 Jun; 39(5):1362-7. PubMed ID: 17580140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting treatment costs and life expectancy for end-stage renal disease.
    Stange PV; Sumner AT
    N Engl J Med; 1978 Feb; 298(7):372-8. PubMed ID: 340947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement therapy options from an Indian perspective: dialysis versus transplantation.
    Singh P; Bhandari M
    Transplant Proc; 2004 Sep; 36(7):2013-4. PubMed ID: 15518728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home hemodialysis à la carte: a tailormade program (1998-2003).
    Piccoli GB; Bermond F; Mezza E; Soragna G; Burdese M; Jeantet A; Segoloni GP; Piccoli G
    J Nephrol; 2004; 17(1):76-86. PubMed ID: 15151262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.